1 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.Fertil Steril,2004,81:19-25. 2 Sartor BM,Dickey RP.Polycystic ovarian syndrome and the metabolic syndrome.Am J Med Sci,2005,330:336-342. 3 Cheung LP,Ma RC,Lam PM,et al.Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.Hum Reprod,2008,23:1431-1438. 4 Apridonidze T,Essah PA,Iuorno MJ,et al.Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.J Clin Endocrinol Metab,2005,90:1929-1935. 5 陈子江.高度重视多囊卵巢综合征的规范化诊断与治疗.中华妇产科杂志,2007,42:289-290. 6 吴玉文,张木勋,张建华,等.多囊卵巢综合征患者血浆酰化刺激蛋白水平变化与血脂相关性研究.中华内分泌代谢杂志,2008,24:513-516. 7 Third Report of the National Cholesterol Education Program (NCEP).Expert panel on detection,evaluation,and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report.Circulation,2002,106:3143-3421. 8 Legro RS,Driscoll D,Strauss JF 3rd,et al.Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.Proc Natl Acad Sci U S A,1998,95: 14956-14960. 9 Stamets K,Taylor DS,Kunselman A,et al.A randomised trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome.Fertil Steril,2004,81:630 637. 10 Schulze MB,Rimm EB,Shai I,et al.Relationship between adiponectin and glycemic control,blood lipids,and inflammatory markers in men with type 2 diabetes.Diabetes Care,2004,27:1680-1687. 11 Cianflone K,Sniderman AD,Walsh MJ,et a1.Purification and characterization of acylation stimulating protein.J Biol Chem,1989,264:426-430. 12 Cianflone K.Maslowska M,Sniderman AD.Acylation stimulatingprotein(ASP),an adipocyte autocrine:new directions.Semin Cell Dev Biol,1999,10:31-41. 13 Kalant D,Cain SA,Maslowska M,et a1.The chemoattractant receptor-like protein C52 binds the C3a des—Ar977/aeylation stimulating protein.J Biol Chem,2003,278:11123-11129.
